Esophageal Balloon Dilatation for Achalasia in Older Adults

Achalasia is an uncommon oesophageal motility disorder in which the lower oesophageal sphincter fails to relax and the oesophageal body loses effective peristalsis. Food and fluid accumulate above the gastro-oesophageal junction, causing dysphagia, regurgitation, chest discomfort, coughing and gradual weight loss. In older people, these symptoms may be mistaken for reflux, dental problems or general frailty.

Pneumatic balloon dilatation is an established endoscopic treatment that stretches and partially disrupts the lower sphincter muscle. For carefully selected older adults, it can relieve swallowing difficulty without the larger physiological burden of surgery. Age alone, however, should not determine treatment. Frailty, cardiopulmonary disease, anticoagulant use, aspiration risk and the patient’s goals are central to safe planning.

Australian care is commonly coordinated through gastroenterologists, surgeons, anaesthetists, dietitians and speech pathologists. Patients in Sydney, Melbourne, Brisbane and other major centres may have access to several treatment options, while people from regional or remote areas may require travel, telehealth review and coordinated follow-up through public hospitals or private clinics.

How Balloon Dilatation Works

During the procedure, an endoscope guides a wire and controlled balloon to the lower oesophageal sphincter. The balloon is inflated for a specified period, creating a radial force that weakens the muscle and improves passage into the stomach. Treatment is usually performed with sedation or anaesthesia, depending on the centre and the patient’s medical condition.

Pneumatic dilation is often delivered in stages, beginning with a smaller balloon and progressing if symptoms persist. Clinical response can be durable, although some people require repeat treatment. The approach differs from a standard diagnostic endoscopy because the therapeutic balloon applies significant pressure to the sphincter.

Why It Can Suit Older Patients

For an older adult with substantial anaesthetic or surgical risk, balloon therapy may offer a less invasive route to improved nutrition and swallowing. It avoids abdominal incisions and may involve a shorter recovery period than laparoscopic Heller myotomy. This can be valuable when sarcopenia, frailty or multiple chronic conditions make prolonged hospital recovery undesirable.

A patient’s baseline function matters as much as chronological age. Someone in their late seventies who remains active may tolerate surgery or peroral endoscopic myotomy, while a younger person with severe frailty may be better suited to a carefully staged dilation. Treatment decisions should reflect expected benefit, life expectancy, independence and the ability to attend follow-up appointments.

Assessing Risk Before Treatment

Assessment generally includes endoscopy to exclude obstructing lesions or pseudoachalasia, high-resolution manometry to confirm the diagnosis, and timed barium swallow imaging to evaluate emptying. In an older patient with rapid symptom onset or marked weight loss, clinicians should be especially alert to malignancy at the gastro-oesophageal junction.

Cardiac and respiratory review may be needed before sedation or anaesthesia. The team should document anticoagulants, antiplatelet medicines, diabetes, sleep apnoea, previous aspiration and nutritional status. A soft or liquid diet before treatment may be necessary when retained food increases aspiration risk.

Useful preparation points include:

• Review anticoagulant and antiplatelet management with the treating team.
• Check hydration, weight change and electrolyte status.
• Discuss transport, overnight observation and home support.
• Confirm how urgent symptoms will be managed after discharge.

Complications And Follow-Up

The most serious complication is oesophageal perforation, although it is uncommon when the procedure is performed by an experienced team with appropriate imaging and monitoring. Chest pain, fever, rapid heart rate, breathlessness or worsening swallowing after dilation requires urgent medical assessment. Minor discomfort and transient reflux can occur during recovery.

Reflux is an important longer-term consideration because weakening the sphincter can allow stomach contents to move upwards. Some patients need acid suppression, dietary adjustments or monitoring for oesophagitis. Symptom improvement should be assessed alongside weight, hydration, pulmonary symptoms and objective oesophageal emptying rather than by swallowing comfort alone.

Comparing Available Treatments

Pneumatic dilation is one option among laparoscopic Heller myotomy, peroral endoscopic myotomy and, in selected cases, botulinum toxin injection. Botulinum toxin may provide short-term relief for people who cannot tolerate more definitive therapy, though repeated injections can complicate later surgery. Myotomy procedures may offer durable control but involve different anaesthetic, procedural and reflux considerations.

The best choice depends on local expertise and patient preference. In Australia, a person may be referred from a regional service to a high-volume oesophageal unit in Melbourne, Sydney or Adelaide. Public waiting lists, private insurance, travel costs and access to specialist follow-up can influence the practical choice, so these issues should be discussed early rather than treated as administrative details.

Shared Decisions In Later Life

Older patients should receive a clear explanation of likely benefits, the possibility of repeat dilation and the warning signs of perforation or aspiration. Family members are often involved in Australian clinical discussions, but the patient’s capacity, preferences and consent remain central. Written instructions in plain language can help when hearing, vision or memory difficulties affect communication.

Research and innovation in oesophageal care also require careful ethical oversight, particularly when new technologies or biological approaches are being considered. Broader debates about consent, risk and vulnerable patients are reflected in discussions of ethical research issues, even though xenotransplantation is separate from achalasia treatment.

A practical plan should match the person, not simply the diagnosis: confirm achalasia, assess frailty and aspiration risk, compare dilation with myotomy-based options, and arrange prompt follow-up with clear emergency instructions. For many older adults, that structured approach makes balloon therapy a reasonable and potentially effective part of specialist care.